Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.09 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: vatiquinone | 0.90 |
| trials ClinicalTrials.gov | 2 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 133 Parkinson's papers of 6,897 | 0.36 |
| pathways Reactome | 3 pathways; mostly iron and oxidative stress | 0.80 |
No case: the score is under the bar. Receipt 2937
Sealed predictions
- NQO1 in dopamine neurons, braak-0.20 (p 0.597) → +0.14 (p 0.722)receipt 2944
Swarm cases
receipt 2944: NQO1 in dopamine neurons, braak
- power
- full sample -0.05 (p 0.847, n 18), 95% CI -0.50 to +0.43. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.05 (p 0.847, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.00 (p 0.997, n 18). could be the mix.
- skeptic
- leave-one-out range -0.16 to +0.05, sign flips 5; without severely affected donors -0.05 (p 0.847, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NQO1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts